References
  1. Cercelaru L, Stepan AE, Mărgăritescu C, et al. EGFR Immunoexpression in Laryngeal Squamous Cell Carcinoma. Curr Health Sci J . 2017; 43(4):340‐344.
  2. Thomas GR, Nadiminti H, Regalado J. Molecular predictors of clinical outcome in patients with head and neck squamous cell carcinoma. Int J Exp Pathol. 2005; 86(6):347‐363.
  3. Rubin Grandis J, Melhem MF, Gooding WE, et al. Levels of TGF-alpha and EGFR protein in head and neck squamous cell carcinoma and patient survival. J Natl Cancer Inst . 1998; 90(11):824‐832.
  4. Pai SI, Westra WH. Molecular pathology of head and neck cancer: implications for diagnosis, prognosis, and treatment. Annu Rev Pathol . 2009; 4:49‐70.
  5. Cortesina G, Martone T. Molecular metastases markers in head and neck squamous cell carcinoma: review of the literature. Acta Otorhinolaryngol Ital . 2006; 26(6):317‐325.
  6. Redaelli de Zinis LO, Nicolai P, Tomenzoli D, et al. The distribution of lymph node metastases in supraglottic squamous cell carcinoma: therapeutic implications. Head Neck. 2002; 24(10):913‐920.
  7. Yilmaz T, Hosal AS, Gedikoğlu G, Onerci M, Gürsel B. Prognostic significance of vascular and perineural invasion in cancer of the larynx. Am J Otolaryngol. 1998; 19(2):83‐88.
  8. Magnano M, Bongioannini G, Lerda W, et al. Lymphnode metastasis in head and neck squamous cells carcinoma: multivariate analysis of prognostic variables. J Exp Clin Cancer Res . 1999; 18(1):79‐83.
  9. Čelakovský P, Kalfeřt D, Smatanová K, Chrobok V, Laco J. Detection of Cervical Lymph Node Micrometastases in Patients with Squamous Cell Carcinoma of the Oral Cavity, Pharynx and Larynx. Acta Medica (Hradec Kralove) . 2015; 58(2):62‐65.
  10. Mayers-Breiting, E., Allvi, G., Zur definition der glottische region. Arch. Otolaryngol.1996; 11:150-152.
  11. Ozdek A, Sarac S, Akyol MU, Unal OF, Sungur A. Histopathological predictors of occult lymph node metastases in supraglottic squamous cell carcinomas. Eur Arch Otorhinolaryngol . 2000; 257(7):389‐392.
  12. Zimmermann M, Zouhair A, Azria D, Ozsahin M. The epidermal growth factor receptor (EGFR) in head and neck cancer: its role and treatment implications. Radiat Oncol. 2006; 1:11. Published 2006 May 2.
  13. Şimşek H, Han Ü, Önal B, Şimişek G. The expression of EGFR, cerbB2, p16, and p53 and their relationship with conventional parameters in squamous cell carcinoma of the larynx. Turk J Med Sci. 2014; 44(3):411‐416.
Tables
Table (1): Show the relation between EGFR expression in cervical lymph node metastasis and T stage & tumor grade (n = 20).